Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Signal Transduction: Overview

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...

Transducer Mechanism: Nuclear Receptors

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Standardized endpoint definitions for trials of transcatheter left atrial appendage closure: a consensus from the Left Atrial Appendage Academic Research Consortium†.

European heart journal·2026

Same author

A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants.

JACC. CardioOncology·2026

Same author

Number of thrombosed venous segments and clinical outcomes in cancer-associated isolated distal deep vein thrombosis: insights from the ONCO DVT Study.

Journal of thrombosis and thrombolysis·2026

Same author

Correction: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.

Molecular medicine (Cambridge, Mass.)·2026

Same author

Characterization of Protein Expression Patterns in <i>Clostridium sporogenes</i> upon Exposure to Rare Earth versus Nonrare Earth Elements.

ACS omega·2026

Same author

Impact of europium and samarium on growth and metabolism of two anaerobic wastewater microorganisms: Sporacetigenium mesophilum and Clostridium sporogenes.

Environmental science and pollution research international·2026

Search research articles

Related Experiment Videos

Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.

Sayoko Ogura¹, Akemi Kakino, Yuko Sato

¹Department of Vascular Physiology, National Cardiovascular Center, Suita, Japan.

Circulation Journal : Official Journal of the Japanese Circulation Society

|October 6, 2009

Summary

Oxidatively modified low-density lipoprotein (oxLDL) drives atherosclerosis by causing endothelial dysfunction. The receptor LOX-1 mediates these effects, offering potential targets for cardiovascular disease diagnosis and treatment.

Related Experiment Videos

Area of Science:

Cardiovascular Biology
Molecular Medicine
Pathophysiology

Background:

Atherosclerosis pathogenesis involves oxidatively modified low-density lipoprotein (oxLDL).
Endothelial dysfunction is an early vascular change preceding atheroma formation.
Lectin-like oxidized LDL receptor-1 (LOX-1) is identified as the primary receptor for oxLDL.

Purpose of the Study:

To review the role of LOX-1 in endothelial dysfunction and atherosclerosis.
To highlight recent advances in LOX-1 genetics and detection methodologies.
To explore the diagnostic and therapeutic potential of LOX-1 in cardiovascular diseases.

Main Methods:

Literature review focusing on LOX-1's function in atherosclerosis.
Analysis of recent genetic and methodological findings related to LOX-1.
Synthesis of information on LOX-1's contribution to cardiovascular pathology.

Main Results:

LOX-1 mediates oxLDL-induced endothelial dysfunction.
LOX-1 contributes to atherosclerotic plaque formation, myocardial infarction, and intimal thickening.
Advancements in LOX-1 genetics and detection are emerging.

Conclusions:

LOX-1 plays a critical role in the pathophysiology of atherosclerosis.
Understanding LOX-1's mechanisms can facilitate the development of new diagnostic and therapeutic strategies.
Targeting LOX-1 presents a promising avenue for cardiovascular disease management.